IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2021 Holdings

Filed 2021-11-16 | 13 holdings | $29.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$29.2M103,20299.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$53.2K936,7770.2%
Alkermes PLC(ALKS)COMG01767105$44.5K1,441,9670.2%
Regeneron Pharmaceuticals(REGN)COM75886F107$44.3K73,1430.2%
United Therapeutics Corp(UTHR)COM91307C102$38.3K207,2870.1%
Taro Pharmaceutical IndusCOMM8737E108$34.7K545,5830.1%
Mckesson Corp(MCK)COM58155Q103$32.8K164,5910.1%
Exelixis Inc(EXEL)COM30161Q104$21.1K1,000,0000.1%
Surgalign Holdings IncCOM86882C105$6.9K6,332,9450.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$6.0K107,7730.0%
Invacare CorpCOM461203101$4.2K891,2590.0%
Travere Therapeutics Inc(TVTX)COM89422G107$3.3K137,2030.0%
Nextcure IncCOM65343E108$20830,9270.0%